The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs. The work is highlighted in the quarterly magazine of the Biotechnology and Biological Sciences Research Council (BBSRC) this week.